ITIF Search

Stephen Ezell


Vice President, Global Innovation Policy, and Director, Center for Life Sciences Innovation

Information Technology and Innovation Foundation

Email: [email protected]

Phone: 202-449-1349

Twitter: @sjezell

Stephen Ezell is vice president for global innovation policy at the Information Technology and Innovation Foundation (ITIF) and director of ITIF’s Center for Life Sciences Innovation. He also leads the Global Trade and Innovation Policy Alliance. His areas of expertise include science and technology policy, international competitiveness, trade, and manufacturing.

Ezell is the coauthor of Innovating in a Service-Driven Economy: Insights, Application, and Practice (Palgrave Macmillan, 2015) and Innovation Economics: The Race for Global Advantage (Yale, 2012).

Ezell came to ITIF from Peer Insight, an innovation research and consulting firm he cofounded in 2003 to study the practice of innovation in service industries. At Peer Insight, Ezell led the Global Service Innovation Consortium, published multiple research papers on service innovation, and researched national service innovation policies being implemented by governments worldwide.

Prior to forming Peer Insight, Ezell worked in the New Service Development group at the NASDAQ Stock Market, where he spearheaded the creation of the NASDAQ Market Intelligence Desk and the NASDAQ Corporate Services Network, services for NASDAQ-listed corporations. Previously, Ezell cofounded two successful innovation ventures, the high-tech services firm Brivo Systems and Lynx Capital, a boutique investment bank.

Ezell holds a B.S. from the School of Foreign Service at Georgetown University, with an honors certificate from Georgetown’s Landegger International Business Diplomacy program.

Recent Publications

September 12, 2022

A New Frontier: Sustaining U.S. High-Performance Computing Leadership in an Exascale Era

Continued leadership in high-performance computing (HPC) as it enters the exascale era remains a key pillar of U.S. industrial competitiveness, economic power, and national security readiness. Policymakers need to sustain investments in HPC applications, infrastructure, and skills to keep America at the leading edge.

August 5, 2022

Senate Reconciliation Legislation Fails to Reconcile the Interests of Biomedical Innovation and Drug Price Affordability

The bill fails to recognize three critical realities: 1) that drug prices are, in fact, not a significant driver of raging inflation; 2) that there exist better mechanisms to reform Medicare Part D drug pricing practices; 3) that mandated government price controls do inflict serious harm on nations’ life-sciences innovation systems.

August 4, 2022

China Gallingly Seeks Greater Influence in Foreign Cultural Markets While Continuing to Severely Restrict Access to Its Own

U.S. policymakers must insist that China comply with its WTO commitments in cultural and entertainment industries and, more broadly, adopt an approach that Chinese enterprises are permitted no more access to U.S. cultural and entertainment markets than U.S. companies receive in China.

July 29, 2022

Three Cheers for the CHIPS and Science Act of 2022! Now, Let’s Get Back to Work

Congressional passage of the legislation represents a tremendous step forward toward renewed U.S. industrial competitiveness, science and technology leadership, and greater levels of innovation to tackle pressing economic and social challenges—but it serves as merely the beginning, not the end of progress toward enacting a national competitiveness agenda.

July 27, 2022

Why the House Needs to Pass the CHIPS and Science Act Today

Some policymakers oppose the legislation, seeing it as merely corporate handouts to an already-profitable industry. But it isn’t about corporate welfare; it’s about the welfare of U.S. industrial competitiveness, defense capability, and the interests of the millions of American jobs the industry supports.

July 25, 2022

How Japan Squandered Its Biopharmaceutical Competitiveness: A Cautionary Tale

Stringent drug price controls have significantly hampered the competitive and innovative capacity of Japan’s biopharmaceutical industry in recent decades, serving as a warning for U.S. policymakers considering introducing Medicare Part D drug price controls in 2022.

July 8, 2022

Senate Democrats’ Drug Price Proposal Would Slow the Pace of New Drug Discovery

Congress should ignore pressure from progressive activists who want to use drug price controls to move to a government-led drug discovery and production system and instead focus on more pragmatic reforms.

June 24, 2022

Postmortem on a Pyrrhic Victory for IP Foes at the WTO

The WTO’s approval of a TRIPS waiver for IP related to COVID-19 vaccines is essentially a shotgun blast completely missing the broadside of a barn.

June 21, 2022

The North American Subnational Innovation Competitiveness Index

The North American innovation ecosystem is increasingly diverse. In collaboration with Macdonald-Laurier Institute, Fundación IDEA, and the Bay Area Economic Council Institute, ITIF compiled this index to identify economic differences among states and provinces and highlight regions needing more federal attention, identify cross-national innovation performance, and track the continent’s overall competitiveness in the innovation-driven global economy.

June 17, 2022

No, America’s Drug Prices Aren’t Climbing Radically Out of Control

The United States uniquely leads the world in innovating new drugs and getting them to patients first while sustaining a globally competitive industry and over time making drugs affordable by incentivizing competition and creating generic pathways.

June 10, 2022

USG Remains Misguided in Endorsing COVID-19 TRIPS IPR Waiver

Instead of conflicting mandates, the Biden administration should articulate a coherent set of policies recognizing that IP represents a fundamental and distinguishing driver of American innovation and technological competitiveness. Support for the TRIPS COVID-19 IPR waiver cannot be consonant with such an agenda.

May 24, 2022

Three Ideas for Four Countries Hunting for Chips: What the Quad Must do to Build a Resilient Semiconductor Chain

Given the hyper-global nature of this supply chain, no one country can become fully self-sufficient. For building a reliable, secure semiconductor supply chain, plurilateral partnerships are a necessity and not a choice.

More publications by Stephen Ezell

Recent Events and Presentations

September 21, 2022

How Can Global Leaders Foster Greater Connectivity in an Increasingly Fractured World?

Stephen Ezell spoke on strengthening semiconductor and high-tech supply chains at the Foreign Policy Tech Forum in New York City.

September 16, 2022

Innovations and the Future of Healthcare

Stephen Ezell will be speaking at the James Madison Institute’s Florida Tech & Innovation 2022 Summit in Coral Gables, Florida on a panel discussing “Innovations and the Future of Healthcare.”

September 15, 2022

A New Frontier: Leveraging U.S. High-Performance Computing Leadership in an Exascale Era

Watch ITIF's event at the Dirksen Senate Office Building (SD-562) as it released a new report exploring the promise of HPC in the exascale era, examining some of the latest cutting-edge applications of HPC, and articulating steps policymakers should take to keep the United States at the leading-edge of this highly globally competitive, yet truly foundational information technology.

August 30, 2022

Why Intellectual Property Rights Matter to Indonesia

Stephen Ezell presented at a conference in Jakarta, Indonesia on August 30, 2022, discussing Why Intellectual Property Rights Matter to Indonesia in advanced-technology industries.

August 18, 2022

US-Korea-China Science and Technology Security

On August 18, Stephen Ezell gave a presentation at the 2022 Annual Conference of the Korea Advanced Institute for Science and Technology (KAIST) annual summit assessing U.S.-China competitiveness in advanced-technology industries and science capabilities.

August 17, 2022

Bottom Up: The Research and Innovation Role in Strengthening Manufacturing Communities

Stephen Ezell gave a presentation on Tuesday, August 16 to the House Manufacturing Caucus on the important role research and innovation plays in strengthening U.S. manufacturing communities and how regional, state, and federal policies can abet them.

August 6, 2022

The Strengths and Weaknesses of America’s National Innovation System

Stephen Ezell will give a presentation to the Academy of Management 82nd Annual Conference on The Strengths and Weaknesses of America’s National Innovation System.

July 27, 2022

Assessing the Competitiveness of North America’s States

Stephen Ezell presented findings from ITIF’s “North American Subnational Innovation Competitiveness Index” report at a webinar hosted by the Association of University Research Parks.

June 21, 2022

Assessing the Competitiveness of North America’s States: The North American Subnational Innovation Competitiveness Index

Watch this virtual event that accompanied the release of a report ranking North American states and provinces on 13 indicators of competitiveness in the increasingly innovation-driven global economy.

May 31, 2022

Why the Bipartisan Innovation Act is Crucial for U.S. National Security

ITIF hosted a discussion on why prompt passage of the BIA during the summer of 2022 is vital for U.S. national security.

May 12, 2022

National Innovation Policies: What Countries Do Best, and How They Can Improve

Stephen Ezell gave a presentation to the National Confederation of Industry Brazil on “National Innovation Policies: What Countries Do Best, and How They Can Improve.”

May 12, 2022

National Innovation Policies: What Countries Do Best and How They Can Improve

Stephen Ezell gave a presentation to Brazil’s Entrepreneurial Mobilization for Innovation committee on “National Innovation Policies: What Countries Do Best and How They Can Improve.”

More Events & Presentations by Stephen Ezell

Back to Top